Original Research
Accepted on 16 Feb 2026
Effect of co-occurring mutations in TP53 gene and TERT promoter on the survival of bladder cancer patients
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
7 articles related to "Co Occurring Mutations"
Articles
Case Report
Published on 12 Dec 2022
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.1042525
- 3,099 views
- 2 citations
Original Research
Published on 26 Aug 2021
Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.628248
- 4,865 views
- 10 citations
Clinical Trial
Published on 22 Apr 2025
Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3-ITD mutations
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1554764
- 2,101 views
Original Research
Published on 20 Jun 2023
Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1107134
- 5,236 views
- 8 citations
Original Research
Published on 21 May 2021
Neurological Characteristics of Pediatric Glycogen Storage Disease
in Pediatric Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.685272
- 11,106 views
- 9 citations
Case Report
Published on 26 Jun 2025
Durable immunotherapeutic response in molecularly complex pulmonary adenosquamous carcinoma: case report and literature review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1614283
- 4,222 views